---
title: "Leveraged ETFs and Event-Driven Stocks See Tactical Inflows Amid Tech Sector Selloff"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294038874.md"
description: "Tactical traders are aggressively utilizing leveraged and inverse funds to navigate heightened market volatility in mid-2026. This roundup highlights shifting institutional flows to hedge against tech sector pullbacks and capitalize on event-driven biotech mergers ahead of crucial quarterly earnings."
datetime: "2026-07-28T09:12:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294038874.md)
  - [en](https://longbridge.com/en/news/294038874.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294038874.md)
---

# Leveraged ETFs and Event-Driven Stocks See Tactical Inflows Amid Tech Sector Selloff

Tactical traders are aggressively rotating capital into US leveraged and inverse exchange-traded funds in July 2026, utilizing these high-beta instruments to navigate a market landscape dominated by Federal Reserve policy shifts and mega-cap technology volatility. According to institutional market monitors, the fragmented risk appetite stemming from sticky inflation and slowing growth has triggered a pronounced volume surge across funds designed to amplify returns or hedge against sharp equity pullbacks.

In the small-cap segment, shifting macro dynamics have sharply influenced capital flows. Cooling inflation fears, spurred by lower oil prices and a pause in geopolitical tensions, recently triggered a strong rebound in the **Direxion Daily Small Cap Bull 3X Shares (TNA.US)**. While the Russell 2000 jumped approximately **20%** by mid-2026—its best showing since 2003—the leveraged fund had previously lagged as investors concentrated their bets on AI-driven large caps. The recent introduction of options expiring in March 2027 is now providing institutions with extended tactical horizons to manage small-cap exposure. Meanwhile, the **ProShares UltraPro S&P 500 (UPRO.US)**, which commands over **USD 5.0 billion** in assets under management, faces renewed structural scrutiny. In a late July 2026 quantitative assessment, analysts warned that the fund's daily leverage reset mechanism leaves it highly exposed to severe volatility decay in sideways markets, emphasizing its strict utility as a short-term trading vehicle rather than a buy-and-hold wealth accumulation asset.

On the other side of the trade, inverse funds are absorbing rapid inflows as a hedge against stretched technology valuations. The **ProShares Short QQQ (PSQ.US)** posted a notable single-day advance in July following a widespread global semiconductor selloff, which was ignited by a 'sell-the-news' reaction to Samsung Electronics' earnings. Prior to this tech pullback, the inverse ETF had faced significant headwinds amid relentless index rallies driven by heavyweights like Meta and Nvidia. According to a late June 2026 note from Zacks Investment Research, the fund remains a prominent short-term opportunity for institutional investors looking to actively hedge their Nasdaq 100 exposure against sudden sector rotations.

Beyond index-linked derivatives, event-driven volatility is accelerating in the life sciences tools sector. **Standard BioTools (LAB.US)** is nearing a transformative industry consolidation, having filed a registration statement in late July 2026 regarding its pending merger with Treeline Biosciences. The company expects to release its Q2 2026 financial results after the US market closes on August 5. Wall Street analysts are closely awaiting this critical disclosure, which is anticipated to establish the fundamental valuation baseline and mass cytometry market share metrics for the newly integrated entity.

_This article does not constitute investment advice._

### Related Stocks

- [LAB.US](https://longbridge.com/en/quote/LAB.US.md)

## Related News & Research

- [Standard BioTools amends 8-K to file mass cytometry sale agreement with Multiplex Bio](https://longbridge.com/en/news/294206092.md)
- [What smart people are saying about Lilian Weng's departure from Thinking Machines Lab](https://longbridge.com/en/news/294097181.md)
- [Why Rocket Lab stock is soaring today](https://longbridge.com/en/news/294403309.md)
- [RKLB Stock Alert: What to Know as Rocket Lab Secures Its Largest Contract Yet](https://longbridge.com/en/news/293962420.md)
- [Standard BioTools gets Nasdaq notice for failing $1 minimum bid price rule](https://longbridge.com/en/news/293795610.md)